Search results
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo News· 1 day agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News· 4 days agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
FDA approves Lilly’s new Alzheimer’s drug after delay
The Hill via Yahoo News· 4 days agoThe Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company...